Executive readout · one minute
Webcast research workspace
Read the call alongside every captured source. 8-K earnings release, 10-K stay in one workspace.
PHIO
$0.87
-2.50%
PHIO
· Phio Pharmaceuticals Corp.
$0.87
-0.02 (-2.50%)
At close · Oct 22
Return incl. dividend (before tax)
Going-concern doubt
— cleared Aug 6, 2026
The latest filing states the doubt was alleviated.
“The Company has limited cash resources, has incurred recurring operating losses and negative cash flows from its operations since its inception and has not yet recognized any product revenues. These factors have previously raised doubt about the Company's ability to continue as a going concern.”View the 10-Q filed Aug 6, 2026
Market Cap
$10.40M
Shares
11.62M
Volume · Oct 22
53.63K
Avg daily vol (3M)
132.5K
All webcasts
Earnings call · FY2025 Q4
Phio Pharmaceuticals Corp. (PHIO) Q4 2025 Earnings Call
Net income · derived Q4
-$2.37M
Research coverage
2 live sources
Open each available source without leaving this research workspace.
Research materials
Open the source you need; every reader stays inside this workspace.
SEC filing · Item 2.02
8-K earnings release
Filed Mar 5, 2026 · complete as-filed document
SEC periodic report
10-K report
Filed Mar 5, 2026 · complete as-filed document